Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Vor Biopharma Inc (VOR)

Vor Biopharma Inc (VOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Vor Bio Reports Promising Clinical Data for Trem-cel + Mylotarg in Acute Myeloid Leukemia Patients Post-Transplant Quiver Quantitative, Inc. - Mon Dec 9, 4:50PM CST

Vor Bio reports improved relapse-free survival and engraftment data from its Phase 1/2 VBP101 study in AML patients.Quiver AI SummaryVor Bio announced promising updates from its Phase 1/2 VBP101 study...

VOR : 0.8673 (-2.19%)
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design GlobeNewswire - Mon Dec 9, 6:30AM CST

VOR : 0.8673 (-2.19%)
Vor Bio to Participate in the Stifel 2024 Healthcare Conference GlobeNewswire - Tue Nov 12, 7:00AM CST

VOR : 0.8673 (-2.19%)
Vor Bio Reports Third Quarter 2024 Financial Results and Provides Company Update GlobeNewswire - Thu Nov 7, 3:05PM CST

VOR : 0.8673 (-2.19%)
PureTech Announces Annual Results for Year Ended December 31, 2022 Business Wire - Fri Apr 28, 2023

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its results for the year ended December 31, 2022, as well as its cash balance as of the first quarter...

PRTC : 20.28 (-3.77%)
PRTC.LN : 154.600 (-3.25%)
BIIB : 146.47 (-0.62%)
KRTX : 329.83 (+0.03%)
VOR : 0.8673 (-2.19%)
AKLI : 0.4320 (-0.62%)
PureTech Provides End of Year Report on Key Progress Business Wire - Thu Dec 22, 2022

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, today...

PRTC : 20.28 (-3.77%)
PRTC.LN : 154.600 (-3.25%)
KRTX : 329.83 (+0.03%)
GLS : 0.1586 (+0.38%)
VOR : 0.8673 (-2.19%)
AKLI : 0.4320 (-0.62%)
BIIB : 146.47 (-0.62%)
PureTech Health plc – Half-Year Report Business Wire - Thu Aug 25, 2022

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”) today announces its half-yearly results for the six months ended June 30, 2022. The following information will be filed...

PRTC : 20.28 (-3.77%)
PRTC.LN : 154.600 (-3.25%)
AKLI : 0.4320 (-0.62%)
GLS : 0.1586 (+0.38%)
DNAA : 14.07 (+47.02%)
RBLX : 60.11 (+2.04%)
CPSR : 7.36 (+9.85%)
KRTX : 329.83 (+0.03%)
VOR : 0.8673 (-2.19%)
Vor Bio to Participate in Upcoming Investor Conferences Globe Newswire - Mon Aug 1, 2022

CAMBRIDGE, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it...

VOR : 0.8673 (-2.19%)
Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA Globe Newswire - Fri Jun 10, 2022

Multiplex deletion of myeloid antigens CD33 and CLL-1 in human hematopoietic stem cells demonstrates potential of next-generation HSC transplants for...

VOR : 0.8673 (-2.19%)
Vor Bio to Participate in Upcoming Investor Conferences Globe Newswire - Wed Jun 1, 2022

CAMBRIDGE, Mass., June 01, 2022 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it...

VOR : 0.8673 (-2.19%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot